An additional patient with bacteria resistant to the antibiotic colistin has been uncovered in the US, according to a report in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report. Colistin, it notes, is typically a treatment of last resort for infections that are multidrug-resistant. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.